Semaglutide Has rapidly emerged as one of the most transformative medications in the treatment of type 2 diabetes and obesity, with significant benefits for cardiovascular health. A member of the GLP-1 receptor agonist class, Semaglutide mimics the natural hormone glucagon-like peptide-1 (GLP-1) in the body, which plays a vital role https://charliecqigl.slypage.com/32099374/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health